<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05087329</url>
  </required_header>
  <id_info>
    <org_study_id>843962</org_study_id>
    <nct_id>NCT05087329</nct_id>
  </id_info>
  <brief_title>Mindfulness Practice in Pregnancy as an Intervention to Decrease Prenatal Stress During the COVID-19 Pandemic</brief_title>
  <acronym>CALMS</acronym>
  <official_title>Mindfulness Practice in Pregnancy as an Intervention to Decrease Prenatal Stress During the COVID-19 Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to examine whether a simple mindfulness intervention conducted&#xD;
      via a virtual platform can reduce stress among pregnant women.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 5, 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in Maternal Stress</measure>
    <time_frame>6 to 8 weeks</time_frame>
    <description>Change in score on Perceived Stress Scale (PSS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite score of maternal morbidity/pregnancy outcomes</measure>
    <time_frame>6 to 8 weeks post-delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in score on Edinburgh Postnatal Depression Scale</measure>
    <time_frame>change between score at time of delivery and 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">248</enrollment>
  <condition>Prenatal Stress</condition>
  <arm_group>
    <arm_group_label>Virtual Mindfulness intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Four weekly group Zoom webinars with a 15-20 minute pre-recorded meditation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Virtual Mindfulness Meditation</intervention_name>
    <description>Four week virtual mindfulness meditation course composed of four weekly group Zoom webinars during which participants will listen to a 15-20 minute pre-recorded meditation, facilitated by a study provider</description>
    <arm_group_label>Virtual Mindfulness intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women between 16w0d-26w6d gestation with a single gestation who have had a confirmed&#xD;
             dating ultrasound&#xD;
&#xD;
             a. Only women with singleton gestations will be included because multiple gestation&#xD;
             pregnancies introduce additional levels of stress and introduce confounding variables&#xD;
             for the adverse composite pregnancy outcome that will be measured. As this is a study&#xD;
             of pregnant patients, only women are included.&#xD;
&#xD;
          2. English speaking&#xD;
&#xD;
             a. The mindfulness meditation trainings have been scripted and recorded in English.&#xD;
             Thus, to understand the recordings and participate in the courses it is necessary for&#xD;
             all participants to speak English.&#xD;
&#xD;
          3. Regular internet access through either phone, tablet or computer. a. Mindfulness&#xD;
             meditations are administered via Zoom webinars so internet access is required. A proxy&#xD;
             for internet access during recruitment will be confirmed by the inclusion of an email&#xD;
             address in the electronic medical record (EMR).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Multiple gestations. This has been chosen as an exclusion criteria to limit&#xD;
             confounding variables for the secondary outcome of composite adverse pregnancy events.&#xD;
&#xD;
          2. Age &lt; 18&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kirstin Leitner, MD</last_name>
    <phone>651-492-3856</phone>
    <email>kirstin.leitner@pennmedicine.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meaghan McCabe</last_name>
    <email>meghan.mccabe@pennmedicine.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsten Leitner, MD</last_name>
      <email>kirsten.leitner@pennmedicine.upenn.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 19, 2021</study_first_submitted>
  <study_first_submitted_qc>October 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Kirstin Leitner</investigator_full_name>
    <investigator_title>Assitant Professor of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

